Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX6HKS
|
||||
Drug Name |
4-(5-nitro-4-(phenylamino)pyrimidin-2-ylamino)benzoic acid
|
||||
Synonyms |
CHEMBL257188
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C17H13N5O4
|
||||
Canonical SMILES |
OC(=O)c1ccc(Nc2ncc(c(Nc3ccccc3)n2)[N+](=O)[O-])cc1
|
||||
InChI |
InChI=1S/C17H13N5O4/c23-16(24)11-6-8-13(9-7-11)20-17-18-10-14(22(25)26)15(21-17)19-12-4-2-1-3-5-12/h1-10H,(H,23,24)(H2,18,19,20,21)
|
||||
InChIKey |
WMSHTIRWIOFMAY-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Aurora kinase A | Target Info | [1587926] | ||
Glycogen synthase kinase-3 | Target Info | [1587926] | |||
KEGG Pathway | Oocyte meiosis | ||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Aurora B signaling | ||||
Signaling by Aurora kinases | |||||
Integrin-linked kinase signaling | |||||
PLK1 signaling events | |||||
Aurora A signalingbetacatenin_deg_pathway:Degradation of beta catenin | |||||
Canonical Wnt signaling pathway | |||||
FOXM1 transcription factor network | |||||
Class I PI3K signaling events mediated by Akt | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.